Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.2331 per EA under NDC 16729036715. Its NADAC has been published 293 times since Oct 14, 2020.
The Low Outlier badge above means this manufacturer's average price in the OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEStrength
12.5; 40 mg/1; mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729036715
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209281On Market Since
9/3/2020
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has been published 293 times since Oct 14, 2020, and over the history we have for it it has declined 69.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2331 per EA |
|---|---|
| All-time high | $0.7675 (Nov 11, 2020) |
| All-time low | $0.1793 (Nov 20, 2024) |
| 52-week high | $0.2376 |
| 52-week low | $0.2149 |
| Median price | $0.2571 |
| Average price | $0.2836 |
| Largest weekly change | -52.4% (Nov 18, 2020) |
| Weeks tracked | 293 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB, manufactured by Accord Healthcare Inc., is $0.2331 per EA (NDC 16729036715), effective May 20, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has declined 69.6%. It has been tracked across 293 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
Since Oct 14, 2020, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB has ranged from a low of $0.1793 (Nov 20, 2024) to a high of $0.7675 (Nov 11, 2020), with a median of $0.2571 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB, but none are currently priced below it.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB (NDC 16729036715) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification